The region has only seen one real initial public offering since the beginning of 2017.
Maryland companies raised $247 million in venture capital funding in the second quarter, the sixth consecutive quarter the state has raised at least $100 million.
AstraZeneca’s MedImmune and 4D Molecular Therapeutics forged a collaboration to develop a gene therapy for chronic lung disease.
Want to hear more about cybersecurity and technology in Montgomery County? Check out the personal stories from our most innovative business leaders and entrepreneurs in the fields of IT, BioHealth, life sciences, and more.
The Bill & Melinda Gates Foundation has held a coming-out party for its nonprofit biotech startup. Equipped with plans to build a 120-person team and spend $100 million a year, the Gates Medical Research Institute (MRI) will turn drug industry expertise and processes on intractable diseases that kill millions of people annually in low- and middle-income countries.
Montgomery County companies may soon apply online for the County’s new Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Matching Grant Program. Applications will be accepted beginning at 10 a.m. on Monday, July 16.
Altimmune, Inc. (Nasdaq:ALT), a clinical-stage immunotherapeutics company focused on infectious disease, today announced it has appointed Mitchel Sayare, Ph.D., as Executive Chairman of the Board, effective immediately.
Johns Hopkins spinout Clear Guide Medical received a $2 million grant from the National Institutes of Health to apply its imaging tools to pediatrics.
A Baltimore biotechnology company has raised $4 million, to help bring its therapeutic treatment targeting rare genetic diseases closer to market.
Venture funding for Greater Washington companies fell nearly 50 percent in the second quarter from a year ago, but the region’s take for the first half of the year remains above last year.